FDA Adverse Event Injury Summary report: N

TLIIQ FETAL FIBRONECTIN TEST

MDR report key: 24795580 · Received April 6, 2026

Report

Report Number
2024800-2026-00017
Event Type
Injury
Date Received
April 6, 2026
Date of Event
April 1, 2026
Report Date
April 6, 2026
Manufacturer
HOLOGIC, INC.
Product Code
LKV
UDI-DI
25420045501154
PMA / PMN Number
P920048
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CUSTOMER NOTED THAT THE SAMPLE IN QUESTION WAS THICK/MUCOIDAL, WHICH MAY IMPACT RESULTS. HOLOGIC PROVIDED CUSTOMER WITH ADDITIONAL GUIDANCE REGARDING SAMPLE COLLECTION AND HANDLING. CUSTOMER REPORTED THERE WAS NO PATIENT SAMPLE REMAINING, AND THEY DID NOT WANT TO SEND THE TLIIQ® ANALYZER OR RELATED MATERIALS BACK TO HOLOGIC FOR INVESTIGATION. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS EVENT.

Description of Event or Problem · 0

ON (B)(6) 2026, CUSTOMER REPORTED RECEIVING DISCREPANT FETAL FIBRONECTIN (FFN) PATIENT RESULTS WHILE USING THE RAPID FFN® CASSETTES (LOT B5913) ON THEIR TLIIQ® ANALYZER (SN (B)(6). THE INITIAL SAMPLE RESULT WAS POSITIVE, AND THE SAME SAMPLE WAS RUN AGAIN TWICE WITHIN TWO HOURS OF THE INITIAL TEST. BOTH RETEST RESULTS WERE NEGATIVE, USING THE SAME CASSETTE LOT (B5913). CUSTOMER CONFIRMED THAT THE DAILY QC (QCETTE SN (B)(6) AND LIQUID CONTROLS (POSITIVE CONTROL LOT 921415; NEGATIVE CONTROL LOT 921416) PASSED WITHOUT ISSUES. CUSTOMER DID NOT PROVIDE INFORMATION REGARDING THE PATIENT, REASON FOR SAMPLE RETEST, OR RESULTS REPORTING. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
852194 TLIIQ FETAL FIBRONECTIN TEST ENZYME IMMUNOASSAY, FETAL FIBRONECTIN LKV HOLOGIC, INC. B5913 25420045501154

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other